Baoji Pharmaceutical Funding: $100M Raised, Series C (2022)
Baoji Pharmaceutical is based in Baoshan, China. It has raised $100M in total funding. Latest round: Series C. Backed by Oriental Fortune Capital.
Baoji Pharmaceutical funding overview
Baoji Pharmaceutical is based in Baoshan, China. Baoji Pharmaceutical has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2022. The round record for Baoji Pharmaceutical runs through 2022; nothing later has been disclosed. Investors on record include Oriental Fortune Capital.
Baoji Pharmaceutical at a glance
Total raised
$100M
Latest round
Series C
Latest round date
August 2022
Headquarters
Baoshan, China
Notable investors
Oriental Fortune Capital
Frequently asked about Baoji Pharmaceutical funding
How much has Baoji Pharmaceutical raised?
Baoji Pharmaceutical has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Baoji Pharmaceutical?
Oriental Fortune Capital are named among the investors backing Baoji Pharmaceutical.
What was the latest Baoji Pharmaceutical funding round?
The most recent disclosed round is a Series C, announced in August 2022.
Where is Baoji Pharmaceutical based?
Baoji Pharmaceutical is based in Baoshan, China.
When did Baoji Pharmaceutical last raise?
The last disclosed Baoji Pharmaceutical round closed in August 2022 at Series C.
Totals shown for Baoji Pharmaceutical aggregate every disclosed round on file. To see how that compares, browse the companies in Baoshan and the investors behind them below.
